I am a clinician scientist trained in medical oncology and cancer genetics. Over the last 10 years I have accumulated expertise in genetics and prostate cancer research though my work at the Centro de Investigación del Cáncer (Salamanca, Spain), The Institute of Cancer Research & The Royal Marsden Hospital (London, UK) and the Spanish National Cancer Research Centre (Madrid, Spain). I have been active in multiple projects focused on assessing the role of genetic variants in prostate cancer and their clinical implications. My work has lead to the identification of BRCA2 germline mutations as an independent prognostic factor for localized and advanced prostate cancer. My current research is focused in the clinical and molecular characterization of BRCA2 and other DNA repair defects in prostate cancer.

In 2019, I joined IBIMA as PI of the GU Traslational Research Unit, after obtaining a “Juan Rodes” grant from Ministry of Science.